In all these reports, the patients did not exhibit a typical Gorlin syndrome phenotype and Smith and Evans highlighted the uncertain pathogenetic significance of the described mutations, prompting that PTCH2 might not be a bona fide Gorlin syndrome predisposition gene [36]. This evidence concerns the gene PTCH2 and nevoid basal cell carcinoma syndrome.